Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI

Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI

Item

http://www.wikidata.org/entity/Q34906145

Q34906145

about

Chondroitin for osteoarthritis Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules Disease-modifying osteoarthritis drugs: in vitro and in vivo data on the development of DMOADs under investigation.First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort.Long-Term Effects of Glucosamine and Chondroitin Sulfate on the Progression of Structural Changes in Knee Osteoarthritis: Six-Year Followup Data From the Osteoarthritis Initiative.Dietary supplements as disease-modifying treatments in osteoarthritis: a critical appraisal Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens.Chondroitin and glucosamine in the management of osteoarthritis: an update.The presence of meniscal lesions is a strong predictor of neuropathic pain in symptomatic knee osteoarthritis: a cross-sectional pilot study.Imaging of cartilage and bone: promises and pitfalls in clinical trials of osteoarthritis.Meniscal extrusion promotes knee osteoarthritis structural progression: protective effect of strontium ranelate treatment in a phase III clinical trial.Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament model Comparison of various SYSADOA for the osteoarthritis treatment: an experimental study in rabbits.Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty Use magnetic resonance imaging to assess articular cartilage.Structural effects of sprifermin in knee osteoarthritis: a post-hoc analysis on cartilage and non-cartilaginous tissue alterations in a randomized controlled trial.Diacerein protects against iodoacetate-induced osteoarthritis in the femorotibial joints of rats.Effect of chondroitin sulfate on soluble biomarkers of osteoarthritis: a method to analyze and interpret the results from an open-label trial in unilateral knee osteoarthritis patients.Groin pain syndrome: an association of different pathologies and a case presentation.A Road Map to Commercialization of Cartilage Therapy in the United States of America.Emerging drugs for osteoarthritis.Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer.A posteriori comparison of natural and surgical destabilization models of canine osteoarthritis.Brief report: intraarticular sprifermin not only increases cartilage thickness, but also reduces cartilage loss: location-independent post hoc analysis using magnetic resonance imaging.Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study.Are we moving in the right direction with osteoarthritis drug discovery?Nutraceuticals in the management of osteoarthritis : a critical review.What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis?Role of modern imaging techniques in hand osteoarthritis research and clinical practice.Discrepancies in composition and biological effects of different formulations of chondroitin sulfate.Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by magnetic resonance imaging: an exploratory study What's new in osteoarthritis pathogenesis?Chondroitin sulphate: a focus on osteoarthritis.Advanced Imaging in Osteoarthritis.Medical application of glycosaminoglycans: a review.Developments in stem cells: implications for future joint replacements.The levels of the adipokines adipsin and leptin are associated with knee osteoarthritis progression as assessed by MRI and incidence of total knee replacement in symptomatic osteoarthritis patients: a post hoc analysis.Chondroitin sulfate prevents peritoneal fibrosis in mice by suppressing NF-κB activation.The interaction between physical activity and amount of baseline knee cartilage.Total Knee Replacement as a Knee Osteoarthritis Outcome: Predictors Derived from a 4-Year Long-Term Observation following a Randomized Clinical Trial Using Chondroitin Sulfate.

P2860

Q24186473-B68012D9-F8DA-4EC7-ADE1-9928D5E42506 Q26865784-D1F8BD0E-EEF6-4EBB-A6A5-47599F6CA9DA Q30588700-3AC9DF7C-6EB2-45AA-B3F3-6FDBB3F96A9E Q30714596-2119D5A1-702A-44D1-9FEB-83A01284B362 Q31046250-6D4D642E-149B-4D06-A3DD-10B1716FA7C9 Q33920880-AAB00DA3-0F78-4CF4-9224-9097E96D8840 Q34396147-52D9C38F-E181-44C8-9476-68B11BCB032B Q34655436-E7024FBB-B823-4CF4-AD7D-8D304E0D7660 Q34967738-5E4310B6-B047-4A9E-AF54-D454D4450DC5 Q35154096-A182B271-23DF-4E6B-A97F-95DAFE890DA2 Q35531158-71C797AE-0F58-4777-8B7E-86637E8D8FFB Q35557938-3192586E-9432-4CA6-9757-79314BD187F8 Q35634428-A7F6EF3C-86F9-48C5-9EB7-66C3A4B1F13D Q35894623-ABC65D84-16E4-4E58-9C85-E4AFA7BF3EA5 Q36059524-E38EAD4E-EFFD-4B81-B62F-E8756D8A4E46 Q36071944-6445B7BF-A17F-454C-8397-E625C0CA0A27 Q36098610-9284F5E0-816B-43BC-8501-F75177BF47E3 Q36156938-7BF6EE1C-9615-4379-957F-9593176D41B2 Q36197192-0692BCBB-1AD4-47FA-9755-EE20D34C525F Q36579908-0C0271BA-22E6-476A-9D11-C7590EE7B59B Q36931658-88B10F36-3726-4953-871D-8924A69051FA Q37261579-3EA73659-42F7-459C-BB6E-FDB98A8A3193 Q37322474-CE1A2D87-5CE5-47DF-BF14-346FE969D6D6 Q37334016-C1442077-6A5B-478A-9B4A-6D259F547D9E Q37391095-0CAD4240-F2BD-45C6-83E5-0FEF1ABE8465 Q37956680-53ED87C8-7908-45E1-8DCA-3E4ED013A82F Q38047227-21206659-61EA-4C71-88DB-C50DA8747748 Q38124227-6EE159A0-E76B-49CE-8B47-2C4EF48212CD Q38172882-76651CA7-C520-4979-8C9C-4C5DEB22F5AE Q38371965-FA58D09A-5B01-447B-A752-802CC4AA1AFA Q38669607-2F5188BE-4C13-4D54-ABDA-EDD2B2C31B89 Q38743370-5B834CFE-8F9F-446A-B167-30A33728EAC2 Q38838064-20AA2D9F-C9F1-43C9-B0D1-2B6F6C817546 Q38924125-7B6FB795-E8EB-48B0-90EA-707265781B7B Q39083233-AC0E5370-369D-4912-A67A-B55D3FA9D65D Q39421343-EC16C291-8948-4A2A-B0E5-D908FDB61E8A Q40218511-45CD965E-211A-4A06-B369-65185449AC5C Q40790185-82002B4C-CE53-46E9-8F7D-C65DC43FB2CE Q40824343-F74FE485-51E6-4F13-A7D7-7D09AEB0386E Q40840820-986F0867-5815-4590-B991-882D744C6CA2

P2860

Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI

Item

http://www.wikidata.org/entity/Q34906145

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu